Academic Content and Language Evaluation of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (14921)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jan 14, 2022 (publication date) through Feb 15, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Hanif H, Ali MJ, Susheela AT, Khan IW, Luna-Cuadros MA, Khan MM, Lau DTY. Update on the applications and limitations of alpha-fetoprotein for hepatocellular carcinoma. World J Gastroenterol 2022; 28(2): 216-229 [PMID: PMC8776528 DOI: 10.3748/wjg.v28.i2.216] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v28/i2/216.htm |
| Number | Citing Articles |
| 1 |
Long Shao, Biyu Zhang, Wei Wu, Gengyan Cui, Mao Liu. A Label-Free Photoelectrochemical Biosensor Based on ZnO/Cs3MnBr5 Heterogeneous Films for Alpha-Fetoprotein Detection. Nanomaterials 2024; 14(13): 1127 doi: 10.3390/nano14131127
|
| 2 |
Li-Yue Sun, Wen-Jian Cen, Xin-Xin Zeng, Yu-Yun Zhong, Ling Deng, Jiao-Jiao Yang, Ming Li, Fang Wang. The Prognostic Value of Alpha-Fetoprotein Ratio in Patients With Resectable Alpha-Fetoprotein-Negative Hepatocellular Carcinoma. The American Surgeon™ 2024; 90(6): 1240 doi: 10.1177/00031348241227202
|
| 3 |
Thaninee Prasoppokakorn, Areeya Buntho, Praewphan Ingrungruanglert, Thodsawit Tiyarattanachai, Tassanan Jaihan, Kittipat Kulkraisri, Darlene Ariyaskul, Chonlada Phathong, Nipan Israsena, Rungsun Rerknimitr, Sombat Treeprasertsuk, Roongruedee Chaiteerakij. Circulating tumor cells as a prognostic biomarker in patients with hepatocellular carcinoma. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-21888-9
|
| 4 |
Qingmei Deng, Xinhui Zhang, Xiaofeng Wan, Xin Zheng, Hongzhi Wang, Jingyu Zhao, Hong-Qiang Wang, Wulin Yang. The chemokine CCL20 can assist AFP in serological diagnosis of hepatocellular carcinoma. Heliyon 2024; 10(5): e26774 doi: 10.1016/j.heliyon.2024.e26774
|
| 5 |
Jia-Mei Dong, Rui-Qi Wang, Ning-Ning Yuan, Jia-Hao Guo, Xin-Yang Yu, Ang-Hui Peng, Jia-Yi Cai, Lei Xue, Zhi-Ling Zhou, Yi-Hao Sun, Ying-Yin Chen. Recent advances in optical aptasensors for biomarkers in early diagnosis and prognosis monitoring of hepatocellular carcinoma. Frontiers in Cell and Developmental Biology 2023; 11 doi: 10.3389/fcell.2023.1160544
|
| 6 |
Yee Hui Yeo, Yi-Te Lee, Hsian-Rong Tseng, Yazhen Zhu, Sungyong You, Vatche G. Agopian, Ju Dong Yang. Alpha-fetoprotein: Past, present, and future. Hepatology Communications 2024; 8(5) doi: 10.1097/HC9.0000000000000422
|
| 7 |
Philip Vutien, Nicole J. Kim, Mindie H. Nguyen. The Diagnosis and Staging of Hepatocellular Carcinoma. Clinics in Liver Disease 2025; 29(1): 33 doi: 10.1016/j.cld.2024.08.007
|
| 8 |
Daniel Rusie, Adriana Mercan Stanciu, Letitia Toma, Elena Laura Iliescu. Correlation Between Serum Alpha-Fetoprotein and Tumour Size in Patients With Hepatocellular Carcinoma Treated With Direct-Acting Antivirals. Cureus 2022; doi: 10.7759/cureus.24506
|
| 9 |
Tian Yang, Nanya Wang, Fengmei Wang, Hongmei Liu, Feng Shen, Guoyue Lv. Refinement and validation of a comprehensive clinical diagnostic model (GAMAD) based on gender, age, multitarget circulating tumour DNA methylation signature and commonly used serological biomarkers for early detection of hepatocellular carcinoma: a multicentre, prospective observational study protocol. BMJ Open 2023; 13(9): e076467 doi: 10.1136/bmjopen-2023-076467
|
| 10 |
Pooja Basthi Mohan, Rajiv Lochan, Shiran Shetty. Biomarker in Hepatocellular Carcinoma. Indian Journal of Surgical Oncology 2024; 15(S2): 261 doi: 10.1007/s13193-023-01858-x
|
| 11 |
Weiwei Guan, Congyue Zhang, Tongguo Miao, Chen Dong, Lu Li, Xiwei Yuan, Dandan Zhao, Rong Ai, Xiaoxiao Zhang, Mengjiao Sun, Haiyan Kang, Yuemin Nan. The Potential of the lncRNAs ADAMTSL4-AS1, AC067931 and SOCS2-AS1 in Peripheral Blood Mononuclear Cells as Novel Diagnostic Biomarkers for Hepatitis B Virus-Associated Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma 2024; : 1221 doi: 10.2147/JHC.S463804
|
| 12 |
Mingxing Li, Tailin Chen, Rongshi Huang, Yanhui Cen, Feilan Zhao, Rong Fan, Guozhen He. Chimeric antigen receptor-T cells targeting AFP-GPC3 mediate increased antitumor efficacy in hepatocellular carcinoma. Arab Journal of Gastroenterology 2025; doi: 10.1016/j.ajg.2024.12.002
|
| 13 |
Ying Li, Ke-Xing Han, Qian Su, Nan Xu, Qin-Xiu Xie, Yu-Feng Gao. Construction of a Lasso regression-based prediction model for development of cirrhosis in chronic hepatitis B. World Chinese Journal of Digestology 2023; 31(7): 282 doi: 10.11569/wcjd.v31.i7.282
|
| 14 |
Sikander S. Gill, Rajwant K. Gill, R. C. Sobti. Handbook of Oncobiology: From Basic to Clinical Sciences. 2024; : 259 doi: 10.1007/978-981-99-6263-1_7
|
| 15 |
Amy B. Kolbe, Michael R. Acord, Geetika Khanna, Cara E. Morin, HaiThuy N. Nguyen, Mitchell A. Rees, Esther Ro, Gary R. Schooler, Judy H. Squires, Ali B. Syed, Elizabeth R. Tang, Alexander J. Towbin, Adina Alazraki. Imaging Findings and Management Strategies for Liver Masses in Children with Predisposition Disorders: A Review by the Pediatric LI-RADS Group. RadioGraphics 2025; 45(1) doi: 10.1148/rg.240063
|
| 16 |
Yiqing Zhu, Bang Xiao, Meng Liu, Meiting Chen, Ningqi Xia, Haiyan Guo, Jinfeng Huang, Zhiyong Liu, Fang Wang. N6-methyladenosine-modified oncofetal lncRNA MIR4435-2HG contributed to stemness features of hepatocellular carcinoma cells by regulating rRNA 2′-O methylation. Cellular & Molecular Biology Letters 2023; 28(1) doi: 10.1186/s11658-023-00493-2
|
| 17 |
Xian‐Yang Qin, Yohei Shirakami, Masao Honda, Shiou‐Hwei Yeh, Kazushi Numata, Ya‐Yun Lai, Chiao‐Ling Li, Feifei Wei, Yali Xu, Kenji Imai, Koji Takai, Makoto Chuma, Nagisa Komatsu, Yutaka Furutani, Luc Gailhouste, Hiroshi Aikata, Kazuaki Chayama, Masaru Enomoto, Ryosuke Tateishi, Kazunori Kawaguchi, Tatsuya Yamashita, Shuichi Kaneko, Katsuya Nagaoka, Motohiko Tanaka, Yutaka Sasaki, Yasuhito Tanaka, Hideo Baba, Kouichi Miura, Sae Ochi, Takahiro Masaki, Soichi Kojima, Tomokazu Matsuura, Masahito Shimizu, Pei‐Jer Chen, Hisataka Moriwaki, Harukazu Suzuki. Serum MYCN as a predictive biomarker of prognosis and therapeutic response in the prevention of hepatocellular carcinoma recurrence. International Journal of Cancer 2024; 155(3): 582 doi: 10.1002/ijc.34893
|
| 18 |
Chao Lv, Nan He, Jie Jie Yang, Jing Jing Xiao, Yan Zhang, Jun Du, Shi Zuo, Hai Yang Li, Huajian Gu. Prediction of 3-year recurrence rate of hepatocellular carcinoma after resection based on contrast-enhanced CT: a single-centre study. The British Journal of Radiology 2023; 96(1145) doi: 10.1259/bjr.20220702
|
| 19 |
Mostafa A. Sharafeldin, Reda A. Suef, Adel A. Mousa, Dina H. Ziadah, Mohamed M.S. Farag. Serum interleukin-10 and alpha-fetoprotein: A combined diagnostic approach for hepatocellular carcinoma in Egyptians with HCV. Pathology - Research and Practice 2024; 258: 155327 doi: 10.1016/j.prp.2024.155327
|
| 20 |
Ani Gvajaia, Michael Imeh, Ali Raza. An Interesting Case of Alpha-Fetoprotein (AFP)-Producing Pancreaticoduodenal Tumor. Cureus 2024; doi: 10.7759/cureus.59384
|
| 21 |
Jianping Zhang, Jing Zhao, Qingtao Wang, Rui Zhang, Yuhong Yue. Evaluating the Commutability of Reference Materials for α-Fetoprotein: Accurate Value Assignment With Multiple Systems and Trueness Verification. Annals of Laboratory Medicine 2024; 44(6): 507 doi: 10.3343/alm.2023.0447
|
| 22 |
Ruiqi Liu, Jiajun Wu, Haiwei Guo, Weiping Yao, Shuang Li, Yanwei Lu, Yongshi Jia, Xiaodong Liang, Jianming Tang, Haibo Zhang. Post‐translational modifications of histones: Mechanisms, biological functions, and therapeutic targets. MedComm 2023; 4(3) doi: 10.1002/mco2.292
|
| 23 |
Alessandro Vitale, Roberta Angelico, Bruno Sensi, Quirino Lai, Emanuele Kauffmann, Irene Scalera, Matteo Serenari, Michael Ginesini, Pierluigi Romano, Alessandro Furlanetto, Francesco D’Amico. What Is the Role of Minimally Invasive Liver Surgery in Treating Patients with Hepatocellular Carcinoma on Cirrhosis?. Cancers 2024; 16(5): 966 doi: 10.3390/cancers16050966
|
| 24 |
Jun Liu, Kevin Park, Ziyang Shen, Hannah Lee, Purnima Geetha, Mohammadreza Pakyari, Li Chai. Immunotherapy, targeted therapy, and their cross talks in hepatocellular carcinoma. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1285370
|
| 25 |
Iván Herrera, Susana Almenara, Pablo Bellot, Cayetano Miralles, Maria Rodriguez, Lucia Gómez-González, José M. Palazón, Sonia Pascual, Pedro Zapater. Tobacco is a Leading Risk Factor for Liver and Extrahepatic Cancers in Patients With Liver Cirrhosis: A Prospective Cohort Study. Journal of Clinical and Experimental Hepatology 2024; 14(6): 101472 doi: 10.1016/j.jceh.2024.101472
|
| 26 |
Junying Ge, Jianzhi Dou, Xifeng Yu, Yue Sun, Haiyan Song, Dazhong Shen. Simultaneous determination of α-fetoprotein and carbohydrate antigens 125 and 19–9 in potential- and spectrum-resolved dual-mode electrochemiluminescence. Microchemical Journal 2024; 199: 110117 doi: 10.1016/j.microc.2024.110117
|
| 27 |
Alok Ghosh Chaudhuri, Saptadip Samanta, Monalisha Dey, N. S. Raviraja, Souvik Dey.
Role of Alpha-Fetoprotein in the Pathogenesis of Cancer
. Journal of Environmental Pathology, Toxicology and Oncology 2024; 43(2): 57 doi: 10.1615/JEnvironPatholToxicolOncol.2023049145
|
| 28 |
Runmin Cao, Honghe Jiang, Guangpeng Liang, Weibin Zhang. SEER-based risk stratification system for patients with primary non-cirrhotic liver cancer. Journal of Cancer Research and Clinical Oncology 2023; 149(13): 12033 doi: 10.1007/s00432-023-05057-7
|
| 29 |
Jintao Liang, Fei Guo, Jiaying Huang, Xiaohong Tan, Lixian Sun, Zhide Zhou, Guiyin Li. An ultrasensitive label-free electrochemical aptasensing platform for Golgi protein-73 detection based on RGO-Fc-Mn3O4 nanocomposites. Microchemical Journal 2023; 193: 109138 doi: 10.1016/j.microc.2023.109138
|
| 30 |
Jintao Liang, Ruijie Yan, Chunguan Chen, Xiaoqing Yao, Fei Guo, Runqiang Wu, Zhide Zhou, Jiejing Chen, Guiyin Li. A novel fluorescent strategy for Golgi protein 73 determination based on aptamer/nitrogen-doped graphene quantum dots/molybdenum disulfide @ reduced graphene oxide nanosheets. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy 2023; 294: 122538 doi: 10.1016/j.saa.2023.122538
|
| 31 |
Ahmad Mobed, Bita Abdi, Sajjad Masoumi, Mohammad Mikaeili, Elham Shaterian, Hamed Shaterian, Esmat Sadat Kazemi, Mahdiye Shirafkan. Advances in human reproductive biomarkers. Clinica Chimica Acta 2024; 552: 117668 doi: 10.1016/j.cca.2023.117668
|
| 32 |
Noor Kadhim Yousif, Safa Asaad Ahmed. Novel Biomarkers in Histopathology: Implications for Diagnosis and Prognosis. European Journal of Medical and Health Research 2024; 2(6): 44 doi: 10.59324/ejmhr.2024.2(6).06
|
| 33 |
Ziheng Huang, Keyue Tian, Yiyuan Xue, Feng Luo. A promising role of noble metal NPs@MOFs in chondrosarcoma management. Nanoscale 2025; 17(6): 2961 doi: 10.1039/D4NR03878A
|
| 34 |
Haibin Tu, Siyi Feng, Lihong Chen, Yujie Huang, Juzhen Zhang, Xiaoxiong Wu. Revolutionising hepatocellular carcinoma surveillance: Harnessing contrast-enhanced ultrasound and serological indicators for postoperative early recurrence prediction. Medicine 2023; 102(35): e34937 doi: 10.1097/MD.0000000000034937
|
| 35 |
Wushuang Gong, Jiaqi Wu, Hong Wei, Zhaopeng Jiang, Ming Wan, Chengwei Wu, Weili Xue, Rao Ma, Xianli Zhou, Hang Zhou. Combining serum AFP and CEUS LI-RADS for better diagnostic performance in Chinese high-risk patients. La radiologia medica 2023; 128(4): 393 doi: 10.1007/s11547-023-01614-9
|
| 36 |
Landon L. Moore, Dongfeng Qu, Sripathi Sureban, Stephanie Mitchell, Kamille Pitts, Nasya Cooper, Javid Fazili, Richard Harty, Abdul Oseini, Kai Ding, Michael Bronze, Courtney W. Houchen. From Inflammation to Oncogenesis: Tracing Serum DCLK1 and miRNA Signatures in Chronic Liver Diseases. International Journal of Molecular Sciences 2024; 25(12): 6481 doi: 10.3390/ijms25126481
|
| 37 |
Amer Latif, Riffat Saeed, Tariq Ali Banghash, Muhammad Khawar Shahzad, Hassam Ahmed, Muhammad Asif Naveed, Usama Amer. Validity of Prothrombin-induced Vitamin K antagonist versus Alpha-Fetoprotein (Tumor Markers) in Diagnosis of Hepatocellular Carcinoma, Using Computed Tomography scan as Gold Standard. Pakistan Journal of Health Sciences 2024; : 158 doi: 10.54393/pjhs.v5i07.1804
|
| 38 |
Bangjie Li, Jialiang Hu, Hanmei Xu. Integrated single-cell and bulk RNA sequencing reveals immune-related SPP1+ macrophages as a potential strategy for predicting the prognosis and treatment of liver fibrosis and hepatocellular carcinoma. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1455383
|
| 39 |
Rita Andrade, Judith Perez-Rojas, Sílvia Gomes da Silva, Migla Miskinyte, Margarida C. Quaresma, Laura P. Frazão, Carolina Peixoto, Almudena Cubells, Eva M. Montalvá, António Figueiredo, Augusta Cipriano, Maria Gonçalves-Reis, Daniela Proença, André Folgado, José B. Pereira-Leal, Rui Caetano Oliveira, Hugo Pinto-Marques, José Guilherme Tralhão, Marina Berenguer, Joana Cardoso. HepatoPredict Accurately Selects Hepatocellular Carcinoma Patients for Liver Transplantation Regardless of Tumor Heterogeneity. Cancers 2025; 17(3): 500 doi: 10.3390/cancers17030500
|
| 40 |
James Yu, Robin Park, Richard Kim. Promising Novel Biomarkers for Hepatocellular Carcinoma: Diagnostic and Prognostic Insights. Journal of Hepatocellular Carcinoma 2023; : 1105 doi: 10.2147/JHC.S341195
|
| 41 |
Rebeca Sierra, Ana Marenco-Flores, Marwan Alsaqa, Romelia Barba, Marcela Cuellar-Lobo, Carla Barberan, Leandro Sierra. Autoimmune Hepatitis Management: Recent Advances and Future Prospects. Livers 2024; 4(2): 240 doi: 10.3390/livers4020017
|
| 42 |
Giuseppe A. Colloca, Antonella Venturino. Radiographic and serologic response in patients with unresectable hepatocellular carcinoma receiving systemic antineoplastic treatments: A trial‐level analysis. Cancer 2024; 130(10): 1773 doi: 10.1002/cncr.35199
|
| 43 |
Sikander S. Gill, Rajwant K. Gill, R. C. Sobti. Handbook of Oncobiology: From Basic to Clinical Sciences. 2023; : 1 doi: 10.1007/978-981-99-2196-6_7-1
|
| 44 |
Fatema Safri, Romario Nguyen, Shadi Zerehpooshnesfchi, Jacob George, Liang Qiao. Heterogeneity of hepatocellular carcinoma: from mechanisms to clinical implications. Cancer Gene Therapy 2024; 31(8): 1105 doi: 10.1038/s41417-024-00764-w
|
| 45 |
Natchaya Polpichai, Sakditad Saowapa, Pojsakorn Danpanichkul, Shu-Yen Chan, Leandro Sierra, Johanna Blagoie, Chitchai Rattananukrom, Pimsiri Sripongpun, Apichat Kaewdech. Beyond the Liver: A Comprehensive Review of Strategies to Prevent Hepatocellular Carcinoma. Journal of Clinical Medicine 2024; 13(22): 6770 doi: 10.3390/jcm13226770
|
| 46 |
David Cheishvili, Chifat Wong, Mohammad Mahbubul Karim, Mohammad Golam Kibria, Nusrat Jahan, Pappu Chandra Das, Md. Abul Khair Yousuf, Md. Atikul Islam, Dulal Chandra Das, Sheikh Mohammad Noor-E-Alam, Moshe Szyf, Sarwar Alam, Wasif A. Khan, Mamun Al Mahtab. A high-throughput test enables specific detection of hepatocellular carcinoma. Nature Communications 2023; 14(1) doi: 10.1038/s41467-023-39055-7
|
| 47 |
Kyeezu Kim, Yinan Zheng, Brian T. Joyce, Drew R. Nannini, Jun Wang, Yishu Qu, Claudia A. Hawkins, Edith Okeke, Olufunmilayo A. Lesi, Lewis R. Roberts, Demirkan B. Gursel, Fatimah B. Abdulkareem, Alani S. Akanmu, Mary J. Duguru, Pantong Davwar, David Paul Nyam, Rahmat A. Adisa, Godwin Imade, Jian-Jun Wei, Masha Kocherginsky, Kwang-Youn Kim, Wasiu L. Adeyemo, Emuobor Odeghe, Firas H. Wehbe, Chad Achenbach, Atiene Sagay, Folasade Ogunsola, Robert L. Murphy, Lifang Hou. Cell-free DNA methylation-based inflammation score as a marker for hepatocellular carcinoma among people living with HIV. Hepatology International 2024; doi: 10.1007/s12072-024-10768-1
|
| 48 |
Haukur Einarsson, Rondell P. Graham. How Do I Diagnose Fibrolamellar Carcinoma?. Modern Pathology 2025; 38(4): 100711 doi: 10.1016/j.modpat.2025.100711
|
| 49 |
Xinjun Sun, Fengyan Fang, Jintong Na, Runjie Yan, Yong Huang, Zhide Zhou, Yongxiang Zhao, Guiyin Li. Fluorescent "turn-on" aptamer sensor for sensitive and reliable detection of Golgi glycoprotein 73 based on nitrogen-doped graphene quantum dots and molybdenum disulfide nanosheets. Journal of Pharmaceutical and Biomedical Analysis 2023; 225: 115215 doi: 10.1016/j.jpba.2022.115215
|
| 50 |
Pratibha Pandey, Deena Elsori, Rahul Kumar, Sorabh Lakhanpal, Indra Rautela, Tariq Mohammed Alqahtani, Fuzail Ahmad, Danish Iqbal, Fahad Khan. Ferroptosis targeting natural compounds as a promising approach for developing potent liver cancer agents. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1399677
|
| 51 |
Yongling Chen, Ziqing Zhong, Xuelian Ruan, Xiuyu Zhan, Yanting Ding, Fangyi Wei, Xue Qin, Hongli Yu, Yu Lu. Novel biomarker in hepatocellular carcinoma: Stearoyl-CoA desaturase 1. Digestive and Liver Disease 2024; doi: 10.1016/j.dld.2024.11.008
|
| 52 |
Lixing Chen, Siyuan Cheng, Dongling Zhu, Guangfa Bao, Ziqiang Wang, Xiaoyun Deng, Xiaoguang Liu, Xiang Ma, Jun Zhao, Lei Zhu, Xiaohua Zhu. Synthesis and Preclinical Evaluation of Dual-Specific Probe Targeting Glypican-3 and Prostate-Specific Membrane Antigen for Hepatocellular Carcinoma PET Imaging. Molecular Pharmaceutics 2025; 22(1): 209 doi: 10.1021/acs.molpharmaceut.4c00838
|
| 53 |
Ioannis D. Kostakis, Nikolaos Kotelis, Danial Safavi, Satheesh Iype. Preoperative blood tests provide diagnostic and prognostic information about patients with hepatocellular carcinoma. European Journal of Gastroenterology & Hepatology 2025; 37(2): 219 doi: 10.1097/MEG.0000000000002896
|
| 54 |
Dong Hwan Kim, Sang Hyun Choi, Boyeon Koo, Se Jin Choi, Hyeon Ji Jang, Subin Heo, Jae Ho Byun, Hyung Jin Won, Yong Moon Shin. Effect of combining serum alpha-fetoprotein with LI-RADS v2018 on gadoxetate-enhanced MRI in the diagnosis and prognostication of hepatocellular carcinoma. European Radiology 2025; doi: 10.1007/s00330-025-11418-2
|
| 55 |
Qu Xie, Zeyin Zhao, Yanzhen Yang, Dan Long, Cong Luo. Radiomics-guided prognostic assessment of early-stage hepatocellular carcinoma recurrence post-radical resection. Journal of Cancer Research and Clinical Oncology 2023; 149(16): 14983 doi: 10.1007/s00432-023-05291-z
|
| 56 |
Pritam Bhagwan Bhosale, Abuyaseer Abusaliya, Hun Hwan Kim, Vetrivel Preethi, Se Hyo Jeong, Min Yeong Park, Chung Kil Won, Jeong Doo Heo, Meejung Ahn, Je Kyung Seong, Gon Sup Kim. Comprehensive analysis of Apigetrin's effects on liver cancer cells: Insights from bioinformatics, in vitro studies, and next-generation transcriptome sequencing. Molecular and Cellular Probes 2025; 79: 102012 doi: 10.1016/j.mcp.2025.102012
|
| 57 |
Wentao Zhu, Pei Shi, An Liang, Ying Zhu, Jiwei Fu, Songsong Yuan, Xiaoping Wu. The combination of serum oligosaccharide chain (G-test), alpha-fetoprotein, and aspartate aminotransferase to alanine aminotransferase ratio provides the optimal diagnostic value for early detection of hepatocellular carcinoma. BMC Cancer 2022; 22(1) doi: 10.1186/s12885-022-10139-9
|
| 58 |
Guoxu Fang, Jianhui Fan, Zongren Ding, Yongyi Zeng. Application of biological big data and radiomics in hepatocellular carcinoma. iLIVER 2023; 2(1): 41 doi: 10.1016/j.iliver.2023.01.003
|
| 59 |
Reem El-Shenawy, Rehab I. Moustafa, Naiera M. Helmy, Yasmine S. El-Abd, Ashraf A. Tabll, Yasser K. Elesnawy, Heba Shawky. Peripheral immune signatures associated with the risk of hepatocarcinogenesis in cirrhotic Egyptian HCV patients before and after treatment with direct-acting antivirals. Virology Journal 2024; 21(1) doi: 10.1186/s12985-024-02551-3
|
| 60 |
Khaled Mahmoud Mohiedeen, Mona Moustafa Tahoon, Christina Samir Sadek Hanna, Mohamed Adel Abdel Aziz. Serum level of hepcidin in cirrhotic patients as a marker for hepatocellular carcinoma. Egyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-023-00307-2
|
| 61 |
Vlad Bogdan Varzaru, Anca-Elena Eftenoiu, Daliborca Cristina Vlad, Cristian Sebastian Vlad, Aurica Elisabeta Moatar, Roxana Popescu, Ionut Marcel Cobec. The Influence of Tumor-Specific Markers in Breast Cancer on Other Blood Parameters. Life 2024; 14(4): 458 doi: 10.3390/life14040458
|
| 62 |
Faezeh Ghorbanizamani, Hichem Moulahoum, Suna Timur. Ionic liquid-reinforced Hydroxyapatite@nano-TiO2 as a green platform for Immuno-electrochemical sensing applications. Talanta 2024; 280: 126688 doi: 10.1016/j.talanta.2024.126688
|
| 63 |
Dimo Stoyanov, George S. Stoyanov, Martin N. Ivanov, Radoslav H. Spasov, Anton B. Tonchev. Transcription Factor Zbtb20 as a Regulator of Malignancy and Its Practical Applications. International Journal of Molecular Sciences 2023; 24(18): 13763 doi: 10.3390/ijms241813763
|
| 64 |
Adonis A Protopapas, Alexandra Tsankof, Ioanna Papagiouvanni, Georgia Kaiafa, Lemonia Skoura, Christos Savopoulos, Ioannis Goulis. Outpatient management after hospitalisation for acute decompensation of cirrhosis: A practical guide. World Journal of Hepatology 2024; 16(12): 1377-1394 doi: 10.4254/wjh.v16.i12.1377
|
| 65 |
Shunwang Cao, Fei Zhong, Xueying Chen, Sikai Ke, Xiangrong Zhong, Tingting Li, Yanhua Sha, Chunmin Kang, Sheng Qin, Hongmei Wang, Yi Wang, Shuzhi Liao, Peifeng Ke. The combination of serum lncRNA PTTG3P and mRNA PTTG1 serves as a diagnostic and prognostic marker for hepatocellular carcinoma. Molecular Medicine Reports 2024; 31(2) doi: 10.3892/mmr.2024.13409
|
| 66 |
Hanna Hong, Chase J. Wehrle, Mingyi Zhang, Sami Fares, Henry Stitzel, David Garib, Bassam Estfan, Suneel Kamath, Smitha Krishnamurthi, Wen Wee Ma, Teodora Kuzmanovic, Elizabeth Azzato, Emrullah Yilmaz, Jamak Modaresi Esfeh, Maureen Whitsett Linganna, Mazhar Khalil, Alejandro Pita, Andrea Schlegel, Jaekeun Kim, R. Matthew Walsh, Charles Miller, Koji Hashimoto, David Choon Hyuck Kwon, Federico Aucejo. Circulating Tumor DNA Profiling in Liver Transplant for Hepatocellular Carcinoma, Cholangiocarcinoma, and Colorectal Liver Metastases: A Programmatic Proof of Concept. Cancers 2024; 16(5): 927 doi: 10.3390/cancers16050927
|
| 67 |
Cheng Zheng, Mengyuan Cui, Yingyu Zhang, Li Liu, Wenqing Li, Jiaqi Zhang, Min Ji, Wei Chen, Wen Jiang, Peng Wang, Wancun Zhang. Universal sulfatase-based chemiluminescence biosensing platform: Validation via AFP detection in clinical blood samples. Biosensors and Bioelectronics 2025; 267: 116771 doi: 10.1016/j.bios.2024.116771
|
| 68 |
Pengfei Ren, Keyan Wang, Jie Ma, Xiaoqin Cao, Jiuzhou Zhao, Chengzhi Zhao, Yongjun Guo, Hua Ye. Autoantibody Against Ferritin Light Chain is a Serum Biomarker for the Detection of Liver Cirrhosis but Not Liver Cancer. Journal of Hepatocellular Carcinoma 2022; : 221 doi: 10.2147/JHC.S352057
|
| 69 |
Joaquin Blanco, Luis D. Gonzalez, Abigail Cortes, Nidia Jimenez, Mario R. Pavia, María X. Gutierrez. Obstructive jaundice as the initial manifestation of hepatocellular carcinoma in a patient with previously unknown chronic hepatitis B infection: a case report and literature review. International Journal of Research in Medical Sciences 2024; 13(1): 374 doi: 10.18203/2320-6012.ijrms20244137
|
| 70 |
Ankit Kumar Dubey, Ishnoor Kaur, Reecha Madaan, Shikha Raheja, Rajni Bala, Manoj Garg, Suresh Kumar, Viney Lather, Vineet Mittal, Deepti Pandita, Rohit Gundamaraju, Rajeev K. Singla, Rohit Sharma. Unlocking the potential of oncology biomarkers: advancements in clinical theranostics. Drug Metabolism and Personalized Therapy 2024; 39(1): 5 doi: 10.1515/dmpt-2023-0056
|
| 71 |
Dattatrya Shetti, Venkata Ramana Mallela, Wenjing Ye, Mahyar Sharif, Filip Ambrozkiewicz, Andriy Trailin, Václav Liška, Kari Hemminki. Emerging role of circulating cell-free RNA as a non-invasive biomarker for hepatocellular carcinoma. Critical Reviews in Oncology/Hematology 2024; 200: 104391 doi: 10.1016/j.critrevonc.2024.104391
|
| 72 |
Rafick Costa Dos Santos Da Silva, Nathalia de Andrade Simon, André Alves Dos Santos, Gabriel De Melo Olegário, Jayne Ferreira Da Silva, Naide Oliveira Sousa, Manuel Alvarez Troncoso Corbacho, Fabrício Freire de Melo. Personalized medicine: Clinical oncology on molecular view of treatment. World Journal of Clinical Oncology 2024; 15(8): 992-1001 doi: 10.5306/wjco.v15.i8.992
|
| 73 |
Huinan Chen, Jingyao Song, Yuanyuan Li, Dongmei Deng, Yuchen Song, Xiaoli Zhu, Liqiang Luo. Cascade signal amplifying strategy for ultrasensitive detection of tumor biomarker by DNAzyme cleaving mediated HCR. Sensors and Actuators B: Chemical 2024; 420: 136466 doi: 10.1016/j.snb.2024.136466
|
| 74 |
Xiaoyun Bin, Yu Luo, Zefeng Sun, Chaoqun Lin, Peng Huang, Zhenbo Tu, Ling Li, Cong Qu, Jiamin Long, Sufang Zhou. The Role of H2-Calponin Antigen in Cancer Metastasis: Presence of Autoantibodies in Liver Cancer Patients. International Journal of Molecular Sciences 2023; 24(12): 9864 doi: 10.3390/ijms24129864
|
| 75 |
Luyao Liu, Lei Liu, Yan Wang, Zheng Fang, Yangyang Bian, Wenyao Zhang, Zhongyu Wang, Xianchun Gao, Changrui Zhao, Miaomiao Tian, Xiaoyan Liu, Hongqiang Qin, Zhimou Guo, Xinmiao Liang, Mingming Dong, Yongzhan Nie, Mingliang Ye. Robust Glycoproteomics Platform Reveals a Tetra‐Antennary Site‐Specific Glycan Capping with Sialyl‐Lewis Antigen for Early Detection of Gastric Cancer. Advanced Science 2024; 11(9) doi: 10.1002/advs.202306955
|
| 76 |
苏淮 于. The Diagnostic Value of Serum G-Test in Hepatocellular Carcinoma. Medical Diagnosis 2023; 13(03): 372 doi: 10.12677/MD.2023.133057
|
| 77 |
Han Li, Chengyuan Zhou, Chenjie Wang, Bo Li, Yanqiong Song, Bo Yang, Yan Zhang, Xueting Li, Mingyue Rao, Jianwen Zhang, Ke Su, Kun He, Yunwei Han. Lasso-Cox interpretable model of AFP-negative hepatocellular carcinoma. Clinical and Translational Oncology 2024; 27(1): 309 doi: 10.1007/s12094-024-03588-0
|
| 78 |
Bing Cong, Pengli Li, Hongling Li, Chenglin Hong, Xiuwen Qiao. A pH-responsive hollow mesoporous SiO2 nanocarrier designed for the ultrasensitive detection of alpha-fetoprotein. New Journal of Chemistry 2023; 47(47): 21916 doi: 10.1039/D3NJ03758D
|
| 79 |
Sravan Jeepalyam, Ankur Sheel, Aslam Ejaz, Eric Miller, Ashish Manne. Is Cell-Free DNA Testing in Hepatocellular Carcinoma Ready for Prime Time?. International Journal of Molecular Sciences 2023; 24(18): 14231 doi: 10.3390/ijms241814231
|
| 80 |
Akiko Eguchi, Motoh Iwasa, Yasuyuki Tamai, Minori Yamada, Koji Okuno, Ryuta Shigefuku, Kyoko Yoshikawa, Mina Tempaku, Koji Sakaguchi, Hideaki Tanaka, Kazushi Sugimoto, Yoshinao Kobayashi, Tetsuji Yamaguchi, Hayato Nakagawa. The prognostic potential of fragmented CK18 serum levels in HCC patients reflecting disease progression and overall hepatocyte damage. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.993705
|
| 81 |
Amparo Roa-Colomo, María Ángeles López Garrido, Pilar Molina-Vallejo, Angela Rojas, Mercedes González Sanchez, Violeta Aranda-García, Javier Salmeron, Manuel Romero-Gomez, Jordi Muntane, Javier Padillo, Jose María Alamo, Jose A. Lorente, María José Serrano, M. Carmen Garrido-Navas. Hepatocellular carcinoma risk-stratification based on ASGR1 in circulating epithelial cells for cancer interception. Frontiers in Molecular Biosciences 2022; 9 doi: 10.3389/fmolb.2022.1074277
|
| 82 |
Elizabeth Zheng, Francis Yao. Real-World Management of Hepatocellular Carcinoma. Clinics in Liver Disease 2025; 29(1): 49 doi: 10.1016/j.cld.2024.08.002
|
| 83 |
Shih-Chung Huang, Chao-Cheng Huang, Chou-Yuan Ko, Cheng-Yi Huang, Ching-Han Liu, Yung-Kuo Lee, Tung-Yuan Chen, Chao-Wen Hsueh, Shiow-Jyu Tzou, Ming-Hong Tai, Tsung-Hui Hu, Ming-Chao Tsai, Wen-Chin Lee, Yu-Cheng Ho, Cheng-Chun Wu, Yi-Chen Chang, Jung-Jui Chang, Kai-Hsi Liu, Chiao-Ching Li, Zhi-Hong Wen, Chen-Lin Chang, Tian-Huei Chu. Slow skeletal muscle troponin T acts as a potential prognostic biomarker and therapeutic target for hepatocellular carcinoma. Gene 2023; 865: 147331 doi: 10.1016/j.gene.2023.147331
|
| 84 |
Motahareh Sadat Raziyan, Arvydas Palevicius, Giedrius Janusas. Review—Electrochemical Biosensors for Alpha-Fetoprotein Detection: Recent Advances and Future Perspectives. Journal of The Electrochemical Society 2024; 171(7): 077510 doi: 10.1149/1945-7111/ad586f
|
| 85 |
Chung-Che Tsai, Chun-Yu Wang, Hsu-Hung Chang, Phebe Ting Syuan Chang, Chuan-Hsin Chang, Tin Yi Chu, Po-Chih Hsu, Chan-Yen Kuo. Diagnostics and Therapy for Malignant Tumors. Biomedicines 2024; 12(12): 2659 doi: 10.3390/biomedicines12122659
|
| 86 |
Yi‐Fan Zhang, Shaoli Lin, Zhen Xiao, Mitchell Ho. A proteomic atlas of glypican‐3 interacting partners: Identification of alpha‐fetoprotein and other extracellular proteins as potential immunotherapy targets in liver cancer. Proteoglycan Research 2024; 2(4) doi: 10.1002/pgr2.70004
|
| 87 |
Jiawei Lin, Jie Li, Yifan Kong, Junhui Yang, Yunjie Zhang, Guoqing Zhu, Zhijie Yu, Jinglin Xia. Construction of a prognostic model for hepatocellular carcinoma patients receiving transarterial chemoembolization treatment based on the Tumor Burden Score. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-12049-4
|
| 88 |
Changjiang Liu, Feng Gao, Jie Yang, Chengang Liu, Ziqiang Tian. Wilms’ Tumor 1-Associating Protein Promotes Nonsmall-Cell Lung Cancer Through the Expression of Carcinoembryonic Antigen-Related Cell Adhesion Molecule 5. American Journal of Clinical Oncology 2024; 47(10): 465 doi: 10.1097/COC.0000000000001116
|
| 89 |
Hengzhou Zhu, Haoyan Chen, Xiaodan Zhu, Baonan Zhang, Chunhui Jin. Diagnostic lncRNA high expression for liver patients prognosis and medication guidance: a systematic review and meta-analysis. Frontiers in Pharmacology 2024; 15 doi: 10.3389/fphar.2024.1462512
|
| 90 |
Josephine Yu Yan Yap, Laura Shih Hui Goh, Ashley Jun Wei Lim, Samuel S. Chong, Lee Jin Lim, Caroline G. Lee. Machine Learning Identifies a Signature of Nine Exosomal RNAs That Predicts Hepatocellular Carcinoma. Cancers 2023; 15(14): 3749 doi: 10.3390/cancers15143749
|
| 91 |
Martyna E. Berej, Joanna J. Kośka, Maria Marta Orzeł, Beata Borek-Dzięcioł. Highly Elevated Alpha-fetoprotein Concentration in a Premature Infant. Journal of Clinical Neonatology 2024; 13(3): 116 doi: 10.4103/jcn.jcn_16_24
|
| 92 |
Marzia Tagliaferro, Mariapaola Marino, Valerio Basile, Krizia Pocino, Gian Ludovico Rapaccini, Gabriele Ciasca, Umberto Basile, Valeria Carnazzo. New Biomarkers in Liver Fibrosis: A Pass through the Quicksand?. Journal of Personalized Medicine 2024; 14(8): 798 doi: 10.3390/jpm14080798
|
| 93 |
Zhiyong Du, Shengju Yin, Bing Liu, Wenxin Zhang, Jiaxu Sun, Meng Fang, Yisheng Xu, Kun Hua, Pengfei Tu, Guoliang Zhang, Ying Ma, Yingyuan Lu. Metabolomics and network analysis uncovered profound inflammation-associated alterations in hepatitis B virus-related cirrhosis patients with early hepatocellular carcinoma. Heliyon 2023; 9(5): e16083 doi: 10.1016/j.heliyon.2023.e16083
|
| 94 |
Maged Tharwat Elghannam, Moataz Hassan Hassanien, Yosry Abdelrahman Ameen, Gamal Mohammed ELattar, Ahmed Aly ELRay, Mohammed Darwish ELTalkawy. Remarkable alpha-fetoprotein elevation and pseudo-infarction of cirrhotic liver: case report. Exploration of Digestive Diseases 2024; : 86 doi: 10.37349/edd.2024.00041
|
| 95 |
Jinxin Sheng, Ri Wang, Haifan Yang, Zhong Zhao, Shichen Qin, Jie Yao, Guang Yang, Xiaowei Cao, Xinghai Yang, Xiaoyong Wang. Surface-enhanced Raman scatting microfluidic chip based on the identification competition strategy were used for rapid and simultaneous detection of liver cancer related proteins. Photodiagnosis and Photodynamic Therapy 2024; 49: 104336 doi: 10.1016/j.pdpdt.2024.104336
|
| 96 |
Lihong Shen, Lijia Shao, Shengchun Feng. Preoperative serum glutathione reductase activity and alpha-fetoprotein level are associated with early postoperative recurrence of hepatocellular carcinoma. Journal of Laboratory Medicine 2025; 49(1): 46 doi: 10.1515/labmed-2024-0035
|
| 97 |
Zhuo Li, Na Zhang, Zewen Dong, Xin Wang, Jian Zhou, Juan Gao, Yunyun Yang, Jing Li, Feng Guan, Yue Zhou, Zengqi Tan. Integrating transcriptomics, glycomics and glycoproteomics to characterize hepatitis B virus-associated hepatocellular carcinoma. Cell Communication and Signaling 2024; 22(1) doi: 10.1186/s12964-024-01569-y
|
| 98 |
Jaume Trapé, Esther Fernández-Galán, Josep Maria Auge, Marina Carbonell-Prat, Xavier Filella, Sílvia Miró-Cañís, Carolina González-Fernández, Stefan Holdenrieder, Huub van Rossum, Michel van den Heuvel. Factors influencing blood tumor marker concentrations in the absence of neoplasia. Tumor Biology 2024; 46(s1): S35 doi: 10.3233/TUB-220023
|
| 99 |
Peng Fu, Binbin Gong, Huiming Li, Qing Luo, Zikun Huang, Renfeng Shan, Junming Li, Shaoying Yan. Combined identification of three lncRNAs in serum as effective diagnostic and prognostic biomarkers for hepatitis B virus‐related hepatocellular carcinoma. International Journal of Cancer 2022; 151(10): 1824 doi: 10.1002/ijc.34201
|
| 100 |
Minami Yamauchi, Masamitsu Maekawa, Toshihiro Sato, Yu Sato, Masaki Kumondai, Mio Tsuruoka, Jun Inoue, Atsushi Masamune, Nariyasu Mano. Liquid Chromatography/Tandem Mass Spectrometry-Based Simultaneous Analysis of 32 Bile Acids in Plasma and Conventional Biomarker-Integrated Diagnostic Screening Model Development for Hepatocellular Carcinoma. Metabolites 2024; 14(9): 513 doi: 10.3390/metabo14090513
|
| 101 |
Brett T. Spear, Martha L. Peterson. Reference Module in Life Sciences. 2024; doi: 10.1016/B978-0-12-822563-9.00211-0
|
| 102 |
Yiwen Lin, Yijie Chen, Chunhui Deng, Nianrong Sun. Integration of resol/block-copolymer carbonization and machine learning: A convenient approach for precise monitoring of glycan-associated disorders. Chinese Chemical Letters 2024; 35(12): 109813 doi: 10.1016/j.cclet.2024.109813
|
| 103 |
Joo Hyun Oh, Jonghyun Lee, Eileen L. Yoon, Soung Won Jeong, Soon Sun Kim, Young Eun Chon, Sang Bong Ahn, Dae Won Jun. Regular Alpha-Fetoprotein Tests Boost Curative Treatment and Survival for Hepatocellular Carcinoma Patients in an Endemic Area. Cancers 2023; 16(1): 150 doi: 10.3390/cancers16010150
|
| 104 |
Bingqiang Zhang, Boyang Zhu, Junmei Yu, He Liu, Yang Zhou, Guolong Sun, Yongchao Ma, Yansong Luan, Mengmeng Chen. A combined model of six serum microRNAs as diagnostic markers for hepatocellular carcinoma. Clinica Chimica Acta 2025; 565: 119977 doi: 10.1016/j.cca.2024.119977
|
| 105 |
Wen Yang, Ling Liu, Jianliang Li, Yingchao Liu, Lin Rong, Junjie Ma, Rongchen Li, Qiuyue Zhang, Yugang Liu. Abnormal expression of miR-668-3p in non-small cell lung cancer patients and its correlation with serum-related tumor markers. Journal of Cardiothoracic Surgery 2025; 20(1) doi: 10.1186/s13019-024-03220-w
|
| 106 |
Xiaoyuan Hu, Fa Huang, Jiyou Yao, Jiaxian Lv, Jialuo Mai, Ning Li, Minqiang Lu. Cross-sectional study on the diagnostic significance of plasma exosomal miRNAs in HBV-related hepatocellular carcinoma. Journal of Translational Medicine 2024; 22(1) doi: 10.1186/s12967-024-05787-3
|
| 107 |
Gavin Wu, Nojan Bajestani, Nooruddin Pracha, Cindy Chen, Mina S. Makary. Hepatocellular Carcinoma Surveillance Strategies: Major Guidelines and Screening Advances. Cancers 2024; 16(23): 3933 doi: 10.3390/cancers16233933
|
| 108 |
Azeez Okikiola Lawal, Tolutope Joseph Ogunniyi, Oriire Idunnuoluwa Oludele, Oluwaloseyi Ayomipo Olorunfemi, Olalekan John Okesanya, Jerico Bautista Ogaya, Emery Manirambona, Mohamed Mustaf Ahmed, Don Eliseo Lucero-Prisno. Innovative laboratory techniques shaping cancer diagnosis and treatment in developing countries. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-01877-w
|
| 109 |
Kohei Chida, Masanori Oshi, Arya Mariam Roy, Takafumi Yachi, Masaki Nara, Kyogo Yamada, Osamu Matsuura, Tadashi Hashizume, Itaru Endo, Kazuaki Takabe. E2F target score is associated with cell proliferation and survival of patients with hepatocellular carcinoma. Surgery 2023; 174(2): 307 doi: 10.1016/j.surg.2023.04.030
|
| 110 |
Xueshuai Wan, Karin Wisskirchen, Tao Jin, Lu Yang, Xiaorui Wang, Xiang’an Wu, Fang Liu, Yu Wu, Christy Ma, Yong Pang, Qi Li, Ke Zhang, Ulrike Protzer, Shunda Du. Genetically-modified, redirected T cells target hepatitis B surface antigen-positive hepatocytes and hepatocellular carcinoma lesions in a clinical setting. Clinical and Molecular Hepatology 2024; 30(4): 735 doi: 10.3350/cmh.2024.0058
|
| 111 |
Jintao Liang, Jianlu Liang, Xinkai Xiao, Fei Guo, Yulian Zhan, Xueqing Zhou, Zhide Zhou, Guiyin Li. A sandwich-type electrochemical sensor based on RGO-CeO2-Au nanoparticles and double aptamers for ultrasensitive detection of glypican-3. Microchimica Acta 2024; 191(11) doi: 10.1007/s00604-024-06704-7
|
| 112 |
Yan Lu, Bo Lin, Mengsen Li. The role of alpha-fetoprotein in the tumor microenvironment of hepatocellular carcinoma. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1363695
|
| 113 |
Yau-Tuen Chan, Cheng Zhang, Junyu Wu, Pengde Lu, Lin Xu, Hongchao Yuan, Yibin Feng, Zhe-Sheng Chen, Ning Wang. Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma. Molecular Cancer 2024; 23(1) doi: 10.1186/s12943-024-02101-z
|
| 114 |
Diana Gabriela Domínguez-Lazcano. Alpha-fetoprotein, glypican-3, and kininogen-1 as biomarkers for the diagnosis of hepatocellular carcinoma. International Journal of Clinical and Experimental Pathology 2024; 17(11): 383 doi: 10.62347/QSII4050
|
| 115 |
Lin Ning, Yuan Tian, Di Chen, Jie Han, Guanyue Xie, Jianguang Sun. Sorafenib safety evaluation: Real-world analysis of adverse events from the FAERS database. Heliyon 2024; 10(18): e37348 doi: 10.1016/j.heliyon.2024.e37348
|
| 116 |
Magdalena Kędzierska, Magdalena Bańkosz. Role of Proteins in Oncology: Advances in Cancer Diagnosis, Prognosis, and Targeted Therapy—A Narrative Review. Journal of Clinical Medicine 2024; 13(23): 7131 doi: 10.3390/jcm13237131
|
| 117 |
Ji Shi, Xu Zhu, Jun-Bo Yang. Advances and challenges in molecular understanding, early detection, and targeted treatment of liver cancer. World Journal of Hepatology 2025; 17(1): 102273 doi: 10.4254/wjh.v17.i1.102273
|
| 118 |
Zhongjing Kang, Kai Jin, Junpeng Jing, Tian jiao Wang. The Value of MRI Combined with AFP, AFP-L3, GP73, and DCP in the Diagnosis of Early Primary Liver Cancer. Disease Markers 2022; 2022: 1 doi: 10.1155/2022/8640999
|
| 119 |
Yuming Shi, Erfan Taherifard, Ali Saeed, Anwaar Saeed. MASLD-Related HCC: A Comprehensive Review of the Trends, Pathophysiology, Tumor Microenvironment, Surveillance, and Treatment Options. Current Issues in Molecular Biology 2024; 46(6): 5965 doi: 10.3390/cimb46060356
|
| 120 |
Hiroko Shimazaki, Haruki Uojima, Kazumi Yamasaki, Tomomi Obayashi, Sayaka Fuseya, Takashi Sato, Masashi Mizokami, Atsushi Kuno. M2BPgs-HCC: An Automated Multilectin Bead Array Indicating Aberrant Glycosylation Signatures Toward Hepatitis C Virus-Associated Hepatocellular Carcinoma Prognosis. Molecules 2024; 29(23): 5640 doi: 10.3390/molecules29235640
|
| 121 |
Manaswita Tappata, Jose D. Debes. Treatment and Management of Tropical Liver Disease. 2025; : 41 doi: 10.1016/B978-0-323-87031-3.00015-9
|
| 122 |
Jonathan Sun, Enric Esplugues, Alicia Bort, Magdalena P. Cardelo, Inmaculada Ruz-Maldonado, Pablo Fernández-Tussy, Clara Wong, Hehe Wang, Iwao Ojima, Martin Kaczocha, Rachel Perry, Yajaira Suárez, Carlos Fernández-Hernando. Fatty acid binding protein 5 suppression attenuates obesity-induced hepatocellular carcinoma by promoting ferroptosis and intratumoral immune rewiring. Nature Metabolism 2024; 6(4): 741 doi: 10.1038/s42255-024-01019-6
|
| 123 |
Azza Mahmoud El Sheashaey, Marium Nagah Al Zafrany Al Agha, Amr ragab Ibrahim shalaby, Salah Mohammed El Kousy, Gamalate Abd Ellatef Elgedawy. Studying of serum bile acids metabolomics as potential biomarkers for differentiation between hepatocellular carcinoma and cholangiocarcinoma. Egyptian Liver Journal 2024; 14(1) doi: 10.1186/s43066-024-00376-x
|
| 124 |
Jinhui Zhou, Yao Zhang, Jing Zhang, Jingbiao Chen, Hang Jiang, Linqi Zhang, Xi Zhong, Tianhui Zhang, Lichun Chen, Yufeng Wang, Yikai Xu, Jin Wang. New strategy of LI-RADS v2018 to improve the sensitivity for small hepatocellular carcinoma ≤ 3.0 cm on extracellular-contrast enhanced MRI. European Journal of Radiology 2024; 181: 111830 doi: 10.1016/j.ejrad.2024.111830
|
| 125 |
Li He, Cui Zhang, Lan-Lan Liu, Li-Ping Huang, Wen-Jing Lu, Yuan-Yuan Zhang, De-Yong Zou, Yu-Fei Wang, Qing Zhang, Xiao-Li Yang. Development of a diagnostic nomogram for alpha-fetoprotein-negative hepatocellular carcinoma based on serological biomarkers. World Journal of Gastrointestinal Oncology 2024; 16(6): 2463-2475 doi: 10.4251/wjgo.v16.i6.2463
Abstract(239) |
Core Tip(279) |
Full Article(HTML)(1000)
|
Full Article with Cover (PDF)-1890K(139)
|
Audio-1381K(2)
|
Peer-Review Report-217K(35)
|
Answering Reviewers-49K(36)
|
Supplementary Material-199K(39)
|
Full Article (PDF)-1577K(59)
|
Full Article (XML)-128K(39)
|
Times Cited (0)
|
Total Visits (2949)
|
Open
|
| 126 |
Subin Heo, So Yeon Kim, So Jung Lee, Seung Soo Lee, Jae Ho Byun, Hyung Jin Won, Yong Moon Shin, Sang Hyun Choi, Claude B. Sirlin. LI-RADS Ultrasound Surveillance Version 2024: Comparison With Version 2017 for Hepatocellular Carcinoma Detection and Risk Factors for Visualization Score C. American Journal of Roentgenology 2025; doi: 10.2214/AJR.24.32433
|
| 127 |
Dongfang Huang, Jianhuai Zhang, Jianbo Xu, Qiang Niu, Dinghua Zhou. Utility of Alpha-Fetoprotein and Ultrasound in the Diagnosis and Prognosis of Patients with Hepatocellular Liver Cancer. Journal of Multidisciplinary Healthcare 2024; : 1819 doi: 10.2147/JMDH.S449276
|